Chronic renal failure. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: For every hemodialysis patient two needles are needed(Arterial needle and venous needle) that insert consecutively, One puncture site was randomly allocated to the experiment and the o
Treatment - Drugs
And other needle as control site scrubbing by placebo (vitamin A and D ointment) as the same amount (0.5 cc) 10 minutes before insertion. After inserting needles, pain intensity will be measured.
For every hemodialysis patient two needles are needed(Arterial needle and venous needle) that insert consecutively, One puncture site was randomly allocated to the experiment and the other one to the
Sponsors
Rafsanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients were included if they were receiving hemodialysis through arteriovenous fistula at least two times a week for three consecutive months, were fully conscious, aged eighteen or more, did not suffer from neuropathies or peripheral vascular problems, had no sign of inflammation at fistula site, received no topical analgesic at fistula site prior to the study intervention, and had no known allergy to Arnigol cream. Exclusion criteria: Unsuccessful puncture at the first attempt and participants’ voluntary withdrawal from the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Immediately after entering needles. Method of measurement: Based on a numerical scale VAS. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed